Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT)

Study acronym: PIMISUTT
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Aug 15, 2026 → Aug 15, 2028
See other at-risk trials from Poitiers University Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 15, 2026 to Aug 15, 2028
    • Eligibility criteria expanded, about 10 words
  2. Primary and study completion dates: Aug 15, 2025 to Aug 15, 2026v7
  3. Eligibility criteria expanded, about 2 wordsv6
  4. Primary completion date: Nov 15, 2021 to Aug 15, 2025
    • Start date: Jan 15, 2021 to Nov 15, 2021
    • Study completion date: Jan 1, 2023 to Aug 15, 2025
    v5
  5. Primary completion date changed from estimate of May 1, 2022 to Nov 15, 2021
    • Study completion date: May 1, 2022 to Jan 1, 2023
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 15, 2020 to Jan 15, 2021
    v3
  2. Primary endpoint revisedv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our study aims to measure metabolic and functional parameters of the infarcted territory by multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the middle cerebral artery and treated by thrombectomy in order to correlate those parameters to clinical outcome (evaluated by modified Rankin score) at 3 months. We aim to find early radiologic predictive factors for favorable clinical outcome in this population of patients.
Trial Details
NCT Number NCT04651010
Lead Sponsor Poitiers University Hospital
Conditions
(from sponsor)		 Middle Cerebral Artery Acute Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov